Xtant Medical Holdings Inc XTNT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $0.45
- Day Range
- $0.44–0.47
- 52-Week Range
- $0.39–0.95
- Bid/Ask
- $0.40 / $0.53
- Shares Outstanding
- 140.26M
- Market Cap
- $62.14M
- Volume/Avg
- 39,856 / 124,487
Key Statistics
- Price/Earnings (Normalized)
- 35.79
- Price/Sales
- 0.54
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 0.10%
Company Profile
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 151
- Website
- http://www.xtantmedical.com
Valuation
|
Metric
|
XTNT
|
|---|---|
Price/Earnings (Normalized) | 35.79 |
Price/Book Value | 1.28 |
Price/Sales | 0.54 |
Price/Cash Flow | 5.42 |
Price/Earnings
XTNT
Financial Strength
|
Metric
|
XTNT
|
|---|---|
Quick Ratio | 1.56 |
Current Ratio | 3.34 |
Interest Coverage | 2.11 |
Quick Ratio
XTNT
Profitability
|
Metric
|
XTNT
|
|---|---|
Return on Assets (Normalized) | 1.88% |
Return on Equity (Normalized) | 3.70% |
Return on Invested Capital (Normalized) | 5.24% |
Return on Assets
XTNT
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|Pz>Z$C | LOCK|s&&> | $155B | |||
| Stryker Corp
SYK
| LOCK|<NjqjnB# | LOCK|Mnc | $121B | |||
| Medtronic PLC
MDT
| LOCK|??#^#L | LOCK|WRLFD | $103B | |||
| Boston Scientific Corp
BSX
| LOCK|xHQCkvt | LOCK|FjNkw | $64B | |||
| Edwards Lifesciences Corp
EW
| LOCK|v@DJ>hLy | LOCK|Ng<bt | $50B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|!<d?>@C | LOCK|Bj | $29B | |||
| DexCom Inc
DXCM
| LOCK|Y@>NZ!vm | LOCK|XW<?m | $28B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|rx | LOCK|@j$ | $26B | |||
| Steris PLC
STE
| LOCK|Ym>MCL | LOCK|NT$# | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|&$TT&@# | LOCK|@qj | $17B |
United States